Cardiol Therapeutics (CRDL)
(Delayed Data from NSDQ)
$1.98 USD
-0.05 (-2.46%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, Cardiol Therapeutics (CRDL) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 30.00%. Look out for CRDL's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year decrease of 42.86%.
Earnings History
Price & Consensus
Zacks News for CRDL
Here's Why You May Invest in Cardiol Therapeutics (CRDL) Stock
CRDL: What are Zacks experts saying now?
Zacks Private Portfolio Services